According to I-Mab Biopharma's latest financial reports the company's current earnings are โฌ3.58 Million. In 2023 the company made an earning of -โฌ26.68 Million, an increase over its 2022 earnings that were of -โฌ48.06 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.